Sensorineural Hearing Loss Treatment Project Selected for Pilot Program
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
Altamira Therapeutics reports that a meta-analysis of nine randomized controlled trials has shown that the oral administration of betahistine, along with the Epley maneuver, is more effective than Epley's maneuver alone.
The article mentions the brain changes that studies have shown may happen when hearing loss remains untreated, potentially causing visual and sensory processing centers to access the auditory cortex, which can result in deterioration of the cortex over time.
The book by Frank Musiek, Jennifer Shinn, Jane Baran, and Raleigh Jones provides the reader with both the audiologic and medical aspects of auditory dysfunction associated with disorders of the peripheral and central auditory system.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
In a recent survey of 2,000 UK adults, commissioned by the British Irish Hearing Instrument Manufacturers Association (BIHIMA) and announced on its website, 16% of respondents self-reported suffering from hearing loss, with men being nearly twice as likely to suffer as women: 1 in 5 men reported suffering from hearing loss compared to 1 in 10 women.
ClearDrum is a “world-first, acoustically optimized” silk fibroin implant for the treatment of chronic middle ear disease (CMED).